BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li XX, Clark RJ, Woodruff TM. C5aR2 Activation Broadly Modulates the Signaling and Function of Primary Human Macrophages. J Immunol 2020;205:1102-12. [PMID: 32611725 DOI: 10.4049/jimmunol.2000407] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhu Y, Wang X, Xu Y, Chen L, Ding P, Chen J, Hu W. An Integrated Analysis of C5AR2 Related to Malignant Properties and Immune Infiltration of Breast Cancer. Front Oncol 2021;11:736725. [PMID: 34595119 DOI: 10.3389/fonc.2021.736725] [Reference Citation Analysis]
2 Lo MW, Kemper C, Woodruff TM. COVID-19: Complement, Coagulation, and Collateral Damage. J Immunol 2020;205:1488-95. [PMID: 32699160 DOI: 10.4049/jimmunol.2000644] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 22.0] [Reference Citation Analysis]
3 Li XX, Clark RJ, Woodruff TM. Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonists. Int Immunopharmacol 2021;100:108074. [PMID: 34454293 DOI: 10.1016/j.intimp.2021.108074] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Wu MCL, Lee JD, Ruitenberg MJ, Woodruff TM. Absence of the C5a Receptor C5aR2 Worsens Ischemic Tissue Injury by Increasing C5aR1-Mediated Neutrophil Infiltration. J Immunol 2020;205:2834-9. [PMID: 33028618 DOI: 10.4049/jimmunol.2000778] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Pandey S, Kumari P, Baidya M, Kise R, Cao Y, Dwivedi-Agnihotri H, Banerjee R, Li XX, Cui CS, Lee JD, Kawakami K, Maharana J, Ranjan A, Chaturvedi M, Jhingan GD, Laporte SA, Woodruff TM, Inoue A, Shukla AK. Intrinsic bias at non-canonical, β-arrestin-coupled seven transmembrane receptors. Mol Cell 2021;81:4605-4621.e11. [PMID: 34582793 DOI: 10.1016/j.molcel.2021.09.007] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Warwick CA, Keyes AL, Woodruff TM, Usachev YM. The complement cascade in the regulation of neuroinflammation, nociceptive sensitization, and pain. J Biol Chem 2021;297:101085. [PMID: 34411562 DOI: 10.1016/j.jbc.2021.101085] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li XX, Kumar V, Clark RJ, Lee JD, Woodruff TM. The "C3aR Antagonist" SB290157 is a Partial C5aR2 Agonist. Front Pharmacol 2020;11:591398. [PMID: 33551801 DOI: 10.3389/fphar.2020.591398] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Sahu SK, Kulkarni DH, Ozanturk AN, Ma L, Kulkarni HS. Emerging roles of the complement system in host-pathogen interactions. Trends Microbiol 2021:S0966-842X(21)00213-4. [PMID: 34600784 DOI: 10.1016/j.tim.2021.09.002] [Reference Citation Analysis]
9 Ort M, Dingemanse J, van den Anker J, Kaufmann P. Treatment of Rare Inflammatory Kidney Diseases: Drugs Targeting the Terminal Complement Pathway. Front Immunol 2020;11:599417. [PMID: 33362783 DOI: 10.3389/fimmu.2020.599417] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Woodruff TM, Shukla AK. The Complement C5a-C5aR1 GPCR Axis in COVID-19 Therapeutics. Trends Immunol 2020;41:965-7. [PMID: 33023856 DOI: 10.1016/j.it.2020.09.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]